You’ve Read the News - Now Find the Expert
Click to discover leading experts on 50,000+ topics for media, events & more.
Discover Experts on 50,000+ TopicsConnect for media, speaking, expert witness inquiries & more.
Experts on 50,000+ TopicsClick to connect to media sources & more.
Powered by:
Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug
investors.com/news/technology/arvinas-stock-breast-cancer-drug-protein-degrader-pfizer
Arvinas stock lost half its value Tuesday after the biotech company reported mixed results from its Pfizer-partnered breast cancer drug.
The post Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-03-11 15:30:45.